Last reviewed · How we verify
NCT03795987: TNT/NW
Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)
NA trial testing NightWare Therapeutic System in Stress Disorders, Post-Traumatic in 15 participants. Completed in 14 August 2019.
14 August 2019
Quick facts
| Lead sponsor | NightWare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 7 February 2019 |
| Primary completion | 14 August 2019 |
| Estimated completion | 14 August 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- NightWare Therapeutic System
Conditions studied
- Stress Disorders, Post-Traumatic — all drugs for Stress Disorders, Post-Traumatic →
- Combat Disorders — all drugs for Combat Disorders →
- Ptsd — all drugs for Ptsd →
- Nightmare — all drugs for Nightmare →
Sponsor
NightWare
Who can join
22 and older, any sex, with Stress Disorders, Post-Traumatic or Combat Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03795987
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NightWare Therapeutic System
Trials testing the same drug.
- NCT04040387 — NightWare Randomized Trial 02 · NA · completed
- NCT03934658 — Remote Study of NightWare for PTSD With Nightmares · NA · completed
- NCT03828656 — NightWare Open Enrollment Study · NA · unknown
Other recruiting trials for Stress Disorders, Post-Traumatic
Currently open trials in the same condition.
- NCT07422077 — Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service · NA · recruiting
- NCT07010770 — SMART Therapist Training: A Hybrid Factorial-SMART Design · NA · recruiting
- NCT06852469 — Computational Assessment of GABA Receptor Modulation in PTSD · Phase 4 · recruiting
- NCT06000475 — Enhancing Memory in CPT for PTSD · NA · recruiting
- NCT06355284 — Overcontrol and Suicide in PTSD · active not recruiting
Other NightWare trials
Trials by the same sponsor.
- NCT04040387 — NightWare Randomized Trial 02 · NA · completed
- NCT03934658 — Remote Study of NightWare for PTSD With Nightmares · NA · completed
- NCT03828656 — NightWare Open Enrollment Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03795987 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NightWare
- Last refreshed: 26 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03795987.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing